Paloma Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,424
Closed -$769K 330
2024
Q3
$769K Buy
+20,424
New +$787K 0.02% 492
2021
Q3
Sell
-3,390
Closed -$203K 1073
2021
Q2
$203K Buy
+3,390
New +$170K ﹤0.01% 1541
2020
Q4
Sell
-6,893
Closed -$225K 1632
2020
Q3
$225K Buy
+6,893
New +$292K 0.01% 1679
2020
Q1
Sell
-6,861
Closed -$297K 1245
2019
Q4
$297K Buy
+6,861
New +$280K ﹤0.01% 1759
2016
Q3
Sell
-11,969
Closed -$256K 1825
2016
Q2
$256K Buy
+11,969
New +$377K ﹤0.01% 1842

Other funds holding ATEX

Paloma Partners's ATEX Position: Q4 2024 in Review

Paloma Partners sold out of Anterix (ATEX) in Q4 2024, closing a stake of 20,424 shares — an estimated $769K sold.

Paloma Partners first reported a position in ATEX in Q2 2016 and held it in 5 quarters. The position peaked at $769K in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Paloma Partners reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 20,424 Anterix shares in Q4 2024, an estimated $769K.
  • Paloma Partners first reported a position in Anterix in Q2 2016 and held it in 5 quarters.
  • Paloma Partners's Anterix position peaked at $769K in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.